Two Sigma Advisers’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.7K | Buy |
+30,900
| New | +$67.7K | ﹤0.01% | 2238 |
|
|
2025
Q1 | – | Sell |
-26,700
| Closed | -$35.5K | – | 2387 |
|
|
2024
Q4 | $35.5K | Buy |
+26,700
| New | +$35.5K | ﹤0.01% | 2306 |
|
|
2024
Q3 | – | Sell |
-45,800
| Closed | -$60.9K | – | 2283 |
|
|
2024
Q2 | $60.9K | Buy |
45,800
+24,900
| +119% | +$33.1K | ﹤0.01% | 2351 |
|
|
2024
Q1 | $41.2K | Sell |
20,900
-40,500
| -66% | -$79.8K | ﹤0.01% | 2361 |
|
|
2023
Q4 | $86.6K | Sell |
61,400
-46,100
| -43% | -$65K | ﹤0.01% | 2341 |
|
|
2023
Q3 | $139K | Sell |
107,500
-60,800
| -36% | -$78.4K | ﹤0.01% | 2162 |
|
|
2023
Q2 | $289K | Sell |
168,300
-293,800
| -64% | -$505K | ﹤0.01% | 1990 |
|
|
2023
Q1 | $836K | Buy |
462,100
+29,300
| +7% | +$53K | ﹤0.01% | 1717 |
|
|
2022
Q4 | $1.15M | Buy |
432,800
+180,400
| +71% | +$480K | ﹤0.01% | 1511 |
|
|
2022
Q3 | $835K | Buy |
252,400
+56,200
| +29% | +$186K | ﹤0.01% | 1612 |
|
|
2022
Q2 | $714K | Buy |
196,200
+115,500
| +143% | +$420K | ﹤0.01% | 1761 |
|
|
2022
Q1 | $411K | Buy |
80,700
+19,400
| +32% | +$98.8K | ﹤0.01% | 2077 |
|
|
2021
Q4 | $468K | Buy |
+61,300
| New | +$468K | ﹤0.01% | 1940 |
|